|
In bringing together our global clinical expertise with country-specific drug development knowledge, our Polish office provides an enhanced level of service to our customers wishing to conduct trials in Poland. This market provides strategic opportunities for the development of new medicines and helps our customers succeed in the global clinical development marketplace.
Kendle's offices in Poland serve as an advisory body for other Central and Eastern European countries, in particular Hungary and the Baltic Countries. They are the primary contact for our contractors in Hungary.
We provide clinical monitoring services for Phase I–IV trials in Poland, including feasibility studies, sites selection, regulatory submissions and monitoring activities. Many of our experienced monitors in Poland have a medical background. We can also provide regulatory consultancy and support at local level.
|
